The DNA glycosylase MUTYH (mutY homolog (Escherichia coli)) counteracts the mutagenic effects of 8-oxo-7,8-dihydroguanine (8-oxodG) by removing adenine (A) misincorporated opposite the oxidized purine. Biallelic germline mutations in MUTYH cause the autosomal recessive MUTYH-associated adenomatous polyposis (MAP). Here we designed new tools to investigate the biochemical defects and biological consequences associated with different MUTYH mutations in human cells. To identify phenotype(s) associated with MUTYH mutations, lymphoblastoid cell lines (LCLs) were derived from seven MAP patients harboring missense as well as truncating mutations in MUTYH. These included homozygous p.Arg245His, p.Gly264TrpfsX7 or compound heterozygous variants (p.Gly396Asp/Arg245Cys, p.Gly396Asp/Tyr179Cys, p.Gly396Asp/Glu410GlyfsX43, p.Gly264TrpfsX7/Ala385ProfsX23 and p.Gly264TrpfsX7/ Glu480del). DNA glycosylase assays of MAP LCL extracts confirmed that all these variants were defective in removing A from an 8-oxoG:A DNA substrate, but retained wild-type OGG1 activity. As a consequence of this defect, MAP LCLs accumulated DNA 8-oxodG in their genome and exhibited a fourfold increase in spontaneous mutagenesis at the PIG-A gene compared with LCLs from healthy donors. They were also hypermutable by KBrO 3 -a source of DNA 8-oxodG-indicating that the relatively modest spontaneous mutator phenotype associated with MUTYH loss can be significantly enhanced by conditions of oxidative stress. These observations identify accumulation of DNA 8-oxodG and a mutator phenotype as likely contributors to the pathogenesis of MUTYH variants.
INTRODUCTION
The DNA glycosylase MUTYH is part of the base excision repair pathway, which counteracts the promutagenic properties of 8-oxo-7,8-dihydroguanine (8-oxodG) , one of the most common base lesions produced by reactive oxygen species. It prevents G:C to T:A transversions by excising adenine (A) misincorporated opposite 8-oxodG in template DNA. [1] [2] [3] The human MUTYH (mutY homolog (Escherichia coli)) gene, is located on chromosome 1p34.3-p32. 1 with an open reading frame of 1.6 kb and 16 exons. 4 Germline biallelic mutations in this gene are implicated in MUTYHassociated polyposis (MAP), a recessively heritable colorectal polyposis, linked to an increased risk of colorectal cancer (CRC). [5] [6] [7] [8] [9] In contrast to familial adenomatous polyposis patients (FAP) who have germline mutations in the adenomatous polyposis coli gene, MAP patients show distinctive somatic G:C to T:A transversions in the adenomatous polyposis coli gene of their tumors. Following the initial discoveries, other groups confirmed these findings and concluded that biallelic mutations in the MUTYH gene drive genomic instability in colorectal epithelial cells resulting in an increased risk of neoplastic transformation in the colon of MAP patients. [10] [11] [12] [13] To date, 4300 MUTYH unique variants among MAP patients and/or controls have been described in the LOVD database, 14 with the p.Tyr179Cys and p.Gly396Asp variants as the most common documented mutations in Caucasian populations. 5, [15] [16] [17] Most MUTYH variants are missense mutations and their effects on protein function can be difficult to predict when present in homozygosity and even more in a genetic condition of compound heterozygosity. In addition, there is a need to set up functional tests that take into account the biological context in which the variants are present. These might represent the basis for establishing genotype-phenotype correlations, thus providing an important tool in clinical practice. Results of our previous study based on an assay in which single mutant MUTYH proteins were expressed in mouse embryonic fibroblasts (MEFs) derived from Mutyh-null mice, showed that accumulation of 8-oxodG is a common phenotype among the investigated MAP-associated variants. 18 To extend these observations to human cells, we derived lymphoblastoid cell lines (LCLs) from MAP patients harboring missense and truncating MUTYH mutations, including compound heterozygotes-a frequent occurrence among Italian MAP patients. We investigated the biochemical defects and biological consequences associated with different MUTYH mutations. The results indicate that the mutator phenotype associated with loss of a functional MUTYH protein in human cells is relatively modest, but can be enhanced by exposure to an oxidative stress.
RESULTS

Expression of MUTYH in LCLs derived from MAP patients
LCLs were established from seven MAP patients carrying biallelic, either compound heterozygous or homozygous, MUTYH variants.
The phenotypic features of these patients are shown in Table 1 . The family history in all biallelic mutation carriers corresponded to an autosomal recessive mode of inheritance, although four patients occurred as sporadic cases (FAP117, FAP278, FAP349 and FAP483). According to the average MAP features, all studied biallelic carriers were phenotypically similar to attenuated adenomatous polyposis coli-polyposis patients and characterized by a limited number of colorectal polyps (range , with the first diagnosis in adult ages (range 37-51 years). The pathology records of four patients (FAP236, FAP349, FAP483 and FAP527) reported, however, co-existing adenomatous and hyperplastic polyps. With the exception of one patient (FAP117), in which adenomas had been detected in small intestine, no apparent extracolonic disease manifestations were observed in the other biallelic mutation carriers.
The position of the variants in relation to the MUTYH coding region together with the estimated locations of the assumed functional domains of the MUTYH protein 14 are shown in Figures  1a and b . The c.933 þ 3A4C (IVS10 þ 3A4C), a transversion causing an aberrant splicing process leading to skipping of exon 10 with the formation of a truncated protein (p.Gly264TrpfsX7) 19 and the predicted truncated gene products of the p.Glu410GlyfsX43 and p.Ala385ProfsX23 mutations are shown in Figure 1b .
Expression of MUTYH in these variants was analyzed by realtime PCR using specific primers and a probe located at the Loss of MUTYH function in human cells V Ruggieri et al junction between exons 5 and 6 of the gene. This allows detecting both mitochondrial and nuclear isoforms of MUTYH. Data from three independent determinations are shown in Figure 2 . The comparison of MUTYH expression levels, normalized using the mean of two housekeeping genes (b-actin and b-tubulin), between seven LCLs from MAP patients and three LCLs from healthy donors indicate that only in one instance MUTYH levels were similar to wild-type cells (p.Tyr179Cys/Gly396Asp; Figure 2a ). Thus, a 20-35% decrease in MUTYH transcripts was observed in four LCLs harboring the p.Arg245Cys/Gly396Asp, p.Gly264TrpfsX7/ Glu480del, p.Arg245His/Arg245His and p.Gly264TrpfsX7/ Gly264TrpfsX7 variants, and these levels were further decreased to 50% of the wild-type protein in LCLs carrying the p.Gly264TrpfsX7/Ala385ProfsX23 and p.Gly396Asp/Glu410-GlyfsX43 variants (Figures 2a and c) .
Protein levels were then measured by western blotting (Figure 2b ). Reproducible levels of the MUTYH protein were observed in three independent experiments and a comparison with two wild-type LCLs (lanes 5 and 6) from healthy donors confirms that in some cell lines (FAP236, FAP182 and FAP527) there is a good correlation between transcripts and protein levels (lanes 1, 2 and 8; Figure 2c ). In other instances, often in LCLs harboring frameshift mutations, no MUTYH or traces of the fulllength protein are detectable (lanes 4 and 9, respectively). It is possible that these truncated proteins might not be identifiable by our antibody that recognizes an epitope at the C-terminus of the protein (aa 435-535). Finally, a low level of the MUTYH protein is also observed in FAP527 LCLs with the homozygous Arg245His mutation (lane 7) suggesting that this specific mutation confers instability to the MUTYH protein.
DNA glycosylase activity in LCLs from MAP patients MUTYH DNA glycosylase activity was assayed by measuring cleavage of 30-mer oligonucleotides containing a single 8-oxodG:A mispair. Extracts of two independent wild-type LCLs, BR806 and BR77 were proficient in A excision (lanes 3-5; Figures  3a and b) . Although MUTYH activity activity is low, the assay reproducibly measured reductions of X50% (examples are shown in Supplementary Figure S1 ). MUTYH DNA glycosylase activity was undetectable in extracts of MAP LCLs (Figures 4a and b) . In the same extract, a dose response for the OGG1-dependent removal of 8-oxodG from a duplex with an 8-oxoG:C mispair was also identified (Supplementary Figures S2a and b) . The activity of OGG1 was similar in MAP and wild-type extracts (examples are shown in Supplementary Figure S2c) . These data confirm the substantially reduced MUTYH activity in MAP LCLs. They indicate further that these cells retain normal levels of OGG1 DNA glycosylase.
Steady-state levels and kinetics of repair of DNA 8-oxodG Inactivation of the mouse MUTYH gene is associated with an accumulation of DNA 8-oxodG observed in MEFs as well as in vivo. 18, 20 To examine the effects of the MUTYH mutations in human cells, we compared steady-state levels of DNA 8-oxodG in MAP LCLs and the two control LCLs. Basal levels of DNA 8-oxodG in the BR77 and BR806 wild-type cell lines were 0.44 and 0.49 residues Â 10 À 6 dG, respectively ( Figure 5a ). Expression of variant MUTYH was associated with increases of 1.3-up to 1.7-fold in DNA 8-oxodG levels (Pp0.02-0.001; Figure 5a ). The two exceptions were cells harboring the p.Gly264TrpfsX7 variant either in homozygosity or in combination with the frameshift mutation To examine whether exposure to an oxidative stress might exacerbate the biological consequences of a MUTYH defect in p.Gly264TrpfsX7/Ala385ProfsX23 LCL, this cell line was compared with wild-type BR77 cells following treatment with the KBrO 3 oxidant (Figure 5b ). The defective processing of 8-oxodG:A mispairs resulted in 8-oxodG repair kinetics much slower than those observed in the wild-type cells, with almost a doubling in the half-life of the lesion (360 vs 180 min). This phenotype is similar to that observed in two other MUTYH defective LCLs expressing 20% or 50% of the MUTYH protein (p.Gly264TrpfsX7/ Glu480del and p.Gly396Asp/Glu410GlyfsX43, respectively; Figure 5b ). Thus, independently from the level of expression of the mutant MUTYH protein, removal of 8-oxodG from the genome was clearly impaired in LCLs derived from MAP patients.
Our findings indicate that MUTYH defects cause an increased steady-state level of DNA 8-oxodG. The differential 8-oxoG accumulation is more marked under conditions of oxidative stress. Expression of significant levels of mutated protein can have a more profound effect that simple loss of MUTYH expression suggesting possible dominant-negative effects.
Measurements of mutation frequencies at the PIG-A gene To investigate whether the defective MUTYH activity in LCLs from MAP patients is associated with increased mutagenesis, we compared the mutation frequency at the X-linked PIG-A locus. Mutations in this gene result in either complete or partial deficiency of membrane glycosylphosphatidylinositol (GPI)-linked proteins and CD48, CD59 and CD55-negative mutant cells can be identified by fluorescence-activated cell sorting analysis 21, 22 ( Figure 6a ). Measurements of mutation frequency in three wildtype cell lines (BR77, BR805 and BR806) yielded a mean value of 21.7 Â 10 À 6 GPI-negative events (10.9, 31.7 and 22.5 Â 10 À 6 , respectively) with modest variations among different determinations (Figure 6b ). This value is in the range of values previously reported for wild-type human cell lines. 21, 22 The mutation frequencies in MAP LCLs were higher with a mean value of 87.6 Â 10 16 GPI-negative events, ranging from 42.2 (the homozygous p.Gly264TrpfsX7) to 157 Â 10
GPI-negative events (p.Arg245His/Arg245His) (Student's t-test, P ¼ 0.04; Figure 6b ).
In order to exclude that this high mutational load was due to a genetic drift of the cell population, GPI-negative cells were eliminated by flow sorting in the p.Gly396Asp/Glu410GlyfsX43 cell line. This sorted cell population was then expanded in vitro for several days and re-analyzed for mutation frequency at the PIG-A gene (Figure 6c ). Once the initial GPI-negative events had been cleared, mutation frequency measured after several days in culture raised up to 149 mutation Â 10 À 6 cells. Thus, fluorescenceactivated cell sorting analysis of this cell population revealed the reappearance of the GPI-negative cells, demonstrating the tendency of this MUTYH-defective cell line to accumulate mutations in the absence of any mutagenic stress. We can conclude that a spontaneous mutator phenotype is a characteristic feature of cells with a defective MUTYH activity.
We have previously shown that MUTYH-defective variants are hypersensitive to killing by KBrO 3 exposure. 18 To investigate whether this sensitivity was associated with enhanced mutability, we compared mutation frequencies in KBrO 3 -treated wild-type BR77 and p.Gly396Asp/Glu410GlyfsX43 LCLs ( Figure 7 ). These MUTYH-defective cells were only slightly more sensitive than BR77 cells to killing by KBrO 3 (Figure 7a ). The number of mutations introduced into the genome by KBrO 3 exposure was, however, much larger in p.Gly396Asp/Glu410GlyfsX43 than in BR77 cells. As a linear increase in mutation frequency was observed as a function of dose in both cell lines (Figures 7b and c) a comparison of the respective slopes (y ¼ 58.5x þ 382 vs y ¼ 14x À 5, respectively) showed an increment of 4.2-fold in the mutagenic response of the MUTYH-defective cell line (Figure 7d ). These data indicate that defective MUTYH confers a hypermutable phenotype under conditions of oxidative stress.
DISCUSSION
MAP is an increasingly studied autosomal recessive disorder. Analysis of the effects of MUTYH mutations is more limited and mainly confined to the most common missense variants. In this study, we characterized several LCLs from MAP patients carrying Loss of MUTYH function in human cells V Ruggieri et al both compound heterozygous and homozygous mutations. Analysis of protein expression in these MAP LCLs indicates that MUTYH transcript levels are not always informative. Indeed the substitution of Arg 245 with His, while modestly affecting the level of transcript, is associated with a significantly reduced protein level. It seems likely that this mutation, which is localized near the 4Fe-4S cluster domain affects protein stability.
When LCLs from MAP patients were analyzed for their glycosylase activity, an impairment in cleavage of an 8-oxodG:Acontaining DNA substrate was identified in all cases. In published reports, with a few exceptions, 23, 24 purified or partially purified MUTYH variants were used to investigate DNA glycosylase activity. [25] [26] [27] [28] [29] [30] [31] The p.Tyr179Cys and p.Arg245His substitutions result in the complete inactivation of MUTYH glycosylase activity, [28] [29] [30] [31] whereas the enzymatic defect conferred by the p.Gly396Asp substitution causes a less severe activity reduction. 27, 28, 30 Our data in LCLs expressing the p.Tyr179Cys/ Gly396Asp (FAP527) and p.Arg245His/Arg245His (FAP483) variants indicate that these modifications are associated with a complete loss of MUTYH enzymatic activity in vivo. In contrast, although the p.Arg245Cys is present in the LOVD variant listing 14 no biochemical data using the purified variant protein are available. By analogy to the His and Leu modifications at this position, which have been demonstrated to inactivate the enzymatic function, 27, 31 structural analysis suggests the pathogenicity of this substitution. The Arginine 245 residue is strictly conserved and is placed in an a-helix perpendicular to the HhH motif. Besides that, because of the close proximity to the iron-sulfur cluster, the presence of an additional cysteine might cause a local rearrangement. The absence of DNA glycosylase activity in FAP182 LCLs where this variant is present in combination with p.Gly396Asp, supports the pathogenetic role of this mutation in MAP. Finally, the frameshift mutations present in FAP349, FAP278 and FAP236 (p.Gly264TrpfsX7, p.Ala385ProfsX23 and p.Glu410GlyfsX43) resulted in severely truncated proteins with loss of 278, 141 and 97 amino acids, respectively. As the deleted regions contain the nucleoside diphosphate linked to moiety X (NUDIX) domain as well as the proliferating cell nuclear antigen-binding region, the absence of MUTYH glycosylase activity in these cells, possibly because of defective binding, is hardly surprising.
We previously demonstrated in rodent cell lines that Mutyh loss is associated with increased steady-state levels of DNA 8-oxodG and expression of some human MUTYH variants leads to a more profound effect in the removal of the oxidized purine than the simple protein loss. 18 This phenotype can also be observed in human cells with defective MUTYH DNA glycosylase activity and an accumulation of DNA 8-oxodG was observed following an oxidative stress induced by KBrO 3 . Even in the absence of g-irradiation) . 18 This phenotype was much more moderate in the case of human LCLs, as shown by data obtained in the p.Gly396Asp/Glu410GlyfsX43 variant and confirmed in the p.Gly264TrpfsX7/Ala385ProfsX23 (data not shown). It is possible that establishment of LCLs by Epstein-Barr virus infection might alter the phenotype associated with MUTYH deficiency. Indeed it has been shown that the EBNA1 protein destabilizes the p53 protein, and decreased level of p53 may increase resistance to apoptosis under oxidative stress. 33 The information on the mutator phenotype associated with MUTYH inactivation is limited to MEFs and embryonic stem cells from Mutyh À / À mice, in which increases in mutation rates varied Loss of MUTYH function in human cells V Ruggieri et al from 2-to 10-fold. 20, 34 The presence of specific G4T transversions in adenomatous polyposis coli or KRAS genes in tumors occurring in MAP patients can also be considered an indirect evidence of a mutator phenotype associated with the presence of a nonfunctional MUTYH. 5, 6, 35, 36 Here we investigated for the first time to which extent MUTYH impairment results in an increased mutation frequency in human cells. The gene we chose for this analysis is the X-linked PIG-A gene that has been successfully used to characterize the mutator phenotype associated with DNA repairdefective human syndromes (Ataxia telangiectasia, Fanconi anemia). 21 When compared with the 21.7 Â 10 À 6 mutational events at the PIG-A gene observed in wild-type cells, the group of LCLs from MAP patients showed a fourfold increased mutation frequency. The reappearance of PIG-A mutants in a cell line with one of the highest mutant frequency (p.Gly396Asp/ Glu410GlyfsX43), following flow sorting to eliminate the preexisting mutant cells, demonstrates that this phenotype is not due to a genetic drift of the cell population but it is an intrinsic feature of these cells. The reported spontaneous mutation rate (m) at this gene for normal cells ranges from 8.8 to 16.5 Â 10 À 7 mutation per cell division. 22 A tentative m-value of 299 Â 10 À 7 mutation per cell division was calculated on the p.Gly396Asp/Glu410GlyfsX43 LCLs following measurement of mutation frequency after six doublings. This value is at least 10-times higher that m-values for normal human cells. 22 These data support the presence of a spontaneous mutator phenotype associated with defective MUTYH proteins and fit quite well with the proposed role of MUTYH variants in favoring the appearance of mutations in oncogenes relevant in the process of colorectal carcinogenesis. 5, 6 As oxidative damage in DNA can contribute to genome instability, we also investigated whether MUTYH inactivation exposes cells to a further increase in their mutational burden in a condition of oxidative stress. Thus, treatment of the biallelic p.Gly396Asp/Glu410GlyfsX43 variant LCLs with an oxidizing agent results indeed in a hypermutable phenotype. Oxidative stress might then have an independent and major role in causing genome instability in the presence of an inactivating MUTYH mutation. Although the mutator phenotype associated with MUTYH defects is considerably milder than that observed in mismatch repair-defective cells, the hypermutability induced by specific genotoxic agents is a shared characteristic of cells with inactivation in either pathway. [37] [38] [39] [40] Thus, we suggest that the level of oxidative damage to DNA bases undergoing in specific districts of the body (and specifically in the gastrointestinal tract) might be a relevant issue to explain the tissue specificity of the increased cancer susceptibility of MUTYH-and mismatch repair-defective patients.
Taken together, these findings support the pathogenic role of the MUTYH mutations in the clinical histories of the MAP patients we analyzed. In addition, the results obtained by these novel functional assays identify the mutator phenotype and oxidative DNA damage as relevant factors, which might contribute to establish informative genotype-phenotype relationships.
MATERIALS AND METHODS
Sample collection and LCL establishment
Lymphocytes of patients and controls were collected from 20 ml of peripheral blood using Lymphoprep solution (Axis-Shield, Dundee, Scotland) according to the manufacturer's instruction and resuspended in 90% fetal bovine serum, 10% dimethylsulphoxide, frozen at À 80 1C and then stored in liquid nitrogen. MUTYH genetic testing was carried out on genomic DNA extracted from lymphocytes. Direct DNA sequencing was carried out on PCR products of exons 1-16 and adjacent intronic regions MUTYH mRNA analysis
Lymphoblastoid cells (2-3 Â 10 6 ) from each MAP patient carrying biallelic MUTYH mutations (FAP117, FAP182, FAP236, FAP278, FAP349, FAP483 and FAP527; Table 1 ) and three controls without MUTYH mutation were pelleted and RNA extracted by EZ1 QIAgen RNA extraction Mini-kit (Qiagen, Germantown, MD, USA). Complementary DNAs were prepared using a Reverse Transcription System kit (Promega, Madison, WI, USA) starting from 1 mg of total RNA. For the quantitative analysis of the MUTYH transcripts, real-time PCR was performed on complementary DNA using the TaqMan Gene Expression Master Mix (Applied Biosystems) and a CFX96 thermal cycler (Bio-Rad, Hercules, CA, USA). Total amount of MUTYH mRNA (nuclear and mitochondrial forms, wild-type and MUT) was detected with a predeveloped TaqMan Gene Expression Assay (Applied Biosystems) containing a FAM-MGB probe directed at the junction between exons 5 and 6. MUTYH signal was normalized by quantization of two different housekeeping genes (b-actin and b-tubulin) with predeveloped assays containing a VIC-MGB probe (Applied Biosystems), allowing to work in duplex condition. To avoid possible contamination with genomic DNA, RNA samples were treated with DNAse during RNA extraction and TaqMan probes sited in exons' junctions were used. Quantitative evaluation of MUTYH expression was carried out by comparing mutant and wild-type samples by the DDCt method.
Western blotting Determination of 8-oxodG 8-OxodG was measured by high-performance liquid chromatography with electrochemical detection as described in ref. 41 . To determine 8-oxodG repair kinetics, cells were treated for 30 min with 20 mM KBrO 3 and at each time point, 1 Â 10 6 cells were removed from dishes, DNA was extracted, and 8-oxodG levels measured as described above.
Preparation of cell extracts
LCLs pellets (4 Â 10 7 cells) were resuspended in 200 ul of lysis buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 Â protease inhibitor cocktail containing 25 mg/ml pestatin A, 50 mg/ml leupeptin and 0.2% aprotinin (Roche Diagnostic S.p.A, Monza, Italy) and 5% glycerol. Cells were frozen at À 80 1C for 2 h and quickly thawed at 30 1C. Samples were then sonicated on ice four times for 10 s each. Cells were cleared by centrifugation at 14 000 r.p.m. for 30 min at 4 1C and the supernatant saved. Protein concentrations were quantified with Bradford reagent (Bio-Rad) and cell extracts aliquoted and stored at À 80 1C.
DNA glycosylase assay
The 8-oxoG:A substrate was a 30-mer double-stranded oligonucleotide containing a single 8-oxodG modification at position 21 in the sequence 5 0 -CCTCTGTGTGCTCAAGGGGGoxoGCTATAAGTTCTTTGC-3 0 , annealed with the complementary strand, 3 0 end labeled with 6-carboxyfluorescein, containing an A at position 16. The 8-oxoG:C substrate differed for the presence of an 8-oxoG:C mispair and was 3 0 end labeled with 6-carboxyfluorescein at the oxidized strand. These high-performance liquid chromatography purified oligonucleotides were purchased from ThermoFisher Scientific Inc., GmbH., Ulm, Germany. Dose response base excision repair reactions were performed by incubating the 30-bp duplex (150 fmol) with increasing amount of LCL cell extracts (30, 60 and 90 mg) in 10 ml of 20 mM Tris-HCl, pH 8, 100 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.1 mg/ml bovine serum albumin buffer at 37 1C for 1 h. The comparison of the DNA glycosylase activity of wild-type and variant MUTYH proteins present in cell extracts was obtained at 90 mg, as measured by Bradford assay. Following the DNA glycosylase reaction, the samples were incubated with NaOH (80 mM) at 90 1C for 4 min to hydrolyze uncleaved abasic sites produced by MUTYH or OGG1. After the addition of a loading dye solution, samples were heated at 90 1C for 2 min. Reaction products were analyzed by 20% denaturing polyacrylamide gel electrophoresis in 1 Â Tris-Borate-EDTA buffer at 500 V for 2 h and 30 min. Fluorescent bands, visualized by Typhoon 9200 Gel Imager (GE Healthcare), were quantified by using the public domain NIH ImageJ software (http:// rsb.info.nih.gov/ij/).
Determination of mutations at the PIG-A gene LCLs are stained on ice with a mixture of phycoerythrin-mouse anti-human antibodies specific for three GPI-linked proteins, anti-CD48 (BD Pharmingen, BD Biosciences, Franklin Lakes, NJ, USA), anti-CD55 (BD Pharmingen), and anti-CD59 (AbD Serotec, Oxford, UK), and with the fluorescein isothiocyanate mouse anti-human leukocyte antigen-DR, (BD Pharmingen), against a non-GPI-anchored transmembrane protein. Mutant cells (GPInegative) are detected as human leukocyte antigen-DR positive but CD48, CD55 and CD59-negative events. Dead cells were excluded by propidium iodide staining (PI/FSC-A), whereas cells doublets were discriminated and excluded by comparing Area and Height signals of Forward scatter parameters (FSC-H/FSC-A). The mutant frequency (f) is calculated as the number of GPI-negative cells divided by the number of total events analyzed. To calculate the mutation rate, preexisting mutants are eliminated by flow sorting on a FACS Aria (BD Biosciences) from the population by collecting the upper 50th percentile of the distribution curve after staining with anti-CD59. Live cells were identified by light scatter characteristics and doublets excluded by pulse width. 31 The collected GPI-positive cells are counted and the new culture re-started with at least 1 Â 10 6 cells in order to minimize fluctuation effects. After expansion (5-7 cell divisions), the cells are again analyzed by flow cytometry using the mixture of all the GPI-linked proteins in order to avoid classifying cells as PIG-A mutant falsely. The mutation rate (m) is calculated using the formula m ¼ fÄd, where d represents the number of cell divisions occurring in vitro after sorting. 22 
Statistical analysis
The effect of each mutation on MUTYH expression and 8-oxodG levels was contrasted, as for its statistical significance, with data relative to the wildtype BR77 and BR806 cultures. The control sample was made of different independent experiments performed in the two wild-type groups, whereas the 'treatment' sample was each time a different mutation. The used statistical test was Student's t-test because the independence of each mutation prevented us to use an analysis of variance þ post hoc testing that is a strongly context-dependent paradigm and must be based on a consistent source of variation. The analysis of PIG-A mutant frequency was performed by Student's t-test having as groups the wild-type cultures contrasted with mutant LCLs considered as a whole.
